CLARITY increases sensitivity and specificity of fluorescence immunostaining in long-term archived human brain tissue.
Alzheimer’s disease
CLARITY
Human brain archive
Immunofluorescence
Post mortem human brain tissue
Super-resolution microscopy (STED, dSTORM)
Synapse
Journal
BMC biology
ISSN: 1741-7007
Titre abrégé: BMC Biol
Pays: England
ID NLM: 101190720
Informations de publication
Date de publication:
24 05 2023
24 05 2023
Historique:
received:
15
09
2022
accepted:
29
03
2023
medline:
25
5
2023
pubmed:
24
5
2023
entrez:
24
5
2023
Statut:
epublish
Résumé
Post mortem human brain tissue is an essential resource to study cell types, connectivity as well as subcellular structures down to the molecular setup of the central nervous system especially with respect to the plethora of brain diseases. A key method is immunostaining with fluorescent dyes, which allows high-resolution imaging in three dimensions of multiple structures simultaneously. Although there are large collections of formalin-fixed brains, research is often limited because several conditions arise that complicate the use of human brain tissue for high-resolution fluorescence microscopy. In this study, we developed a clearing approach for immunofluorescence-based analysis of perfusion- and immersion-fixed post mortem human brain tissue, termed human Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging / Immunostaining / In situ hybridization-compatible Tissue-hYdrogel (hCLARITY). hCLARITY is optimized for specificity by reducing off-target labeling and yields very sensitive stainings in human brain sections allowing for super-resolution microscopy with unprecedented imaging of pre- and postsynaptic compartments. Moreover, hallmarks of Alzheimer's disease were preserved with hCLARITY, and importantly classical 3,3'-diaminobenzidine (DAB) or Nissl stainings are compatible with this protocol. hCLARITY is very versatile as demonstrated by the use of more than 30 well performing antibodies and allows for de- and subsequent re-staining of the same tissue section, which is important for multi-labeling approaches, e.g., in super-resolution microscopy. Taken together, hCLARITY enables research of the human brain with high sensitivity and down to sub-diffraction resolution. It therefore has enormous potential for the investigation of local morphological changes, e.g., in neurodegenerative diseases.
Sections du résumé
BACKGROUND
Post mortem human brain tissue is an essential resource to study cell types, connectivity as well as subcellular structures down to the molecular setup of the central nervous system especially with respect to the plethora of brain diseases. A key method is immunostaining with fluorescent dyes, which allows high-resolution imaging in three dimensions of multiple structures simultaneously. Although there are large collections of formalin-fixed brains, research is often limited because several conditions arise that complicate the use of human brain tissue for high-resolution fluorescence microscopy.
RESULTS
In this study, we developed a clearing approach for immunofluorescence-based analysis of perfusion- and immersion-fixed post mortem human brain tissue, termed human Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging / Immunostaining / In situ hybridization-compatible Tissue-hYdrogel (hCLARITY). hCLARITY is optimized for specificity by reducing off-target labeling and yields very sensitive stainings in human brain sections allowing for super-resolution microscopy with unprecedented imaging of pre- and postsynaptic compartments. Moreover, hallmarks of Alzheimer's disease were preserved with hCLARITY, and importantly classical 3,3'-diaminobenzidine (DAB) or Nissl stainings are compatible with this protocol. hCLARITY is very versatile as demonstrated by the use of more than 30 well performing antibodies and allows for de- and subsequent re-staining of the same tissue section, which is important for multi-labeling approaches, e.g., in super-resolution microscopy.
CONCLUSIONS
Taken together, hCLARITY enables research of the human brain with high sensitivity and down to sub-diffraction resolution. It therefore has enormous potential for the investigation of local morphological changes, e.g., in neurodegenerative diseases.
Identifiants
pubmed: 37221592
doi: 10.1186/s12915-023-01582-6
pii: 10.1186/s12915-023-01582-6
pmc: PMC10207789
doi:
Substances chimiques
Acrylamide
20R035KLCI
Fluorescent Dyes
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Informations de copyright
© 2023. The Author(s).
Références
Ann Neurol. 1991 Oct;30(4):572-80
pubmed: 1789684
Mol Psychiatry. 2020 Jan;25(1):148-167
pubmed: 31391546
Sci Rep. 2015 May 07;5:9808
pubmed: 25950610
Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):E8047-E8056
pubmed: 30082388
Brain Res. 2019 Jan 1;1702:85-95
pubmed: 29274878
Anat Rec (Hoboken). 2014 Jul;297(7):1306-15
pubmed: 24719368
Neuroimage. 2022 Feb 15;247:118832
pubmed: 34929383
Neuroimage. 2018 Nov 15;182:417-428
pubmed: 29196268
Glia. 2007 Jan 15;55(2):165-77
pubmed: 17078026
Brain Res. 1991 Nov 1;563(1-2):184-94
pubmed: 1786532
Front Neuroanat. 2016 Apr 05;10:34
pubmed: 27092059
Mol Neurodegener. 2014 May 26;9:19
pubmed: 24885504
J Neuroinflammation. 2015 Sep 17;12:166
pubmed: 26377085
Acta Neuropathol Commun. 2019 Sep 5;7(1):146
pubmed: 31488214
Acta Neuropathol. 1991;82(4):239-59
pubmed: 1759558
Histochem Cell Biol. 2015 Jul;144(1):93-9
pubmed: 25757745
Ann Neurol. 2013 Jul;74(1):20-38
pubmed: 23686809
Science. 2002 Oct 25;298(5594):789-91
pubmed: 12399581
Front Cell Neurosci. 2012 Apr 03;6:13
pubmed: 22514519
Neurology. 2001 Jan 9;56(1):127-9
pubmed: 11148253
J Neuropathol Exp Neurol. 2000 Aug;59(8):733-48
pubmed: 10952063
Neuropathol Appl Neurobiol. 2017 Jun;43(4):346-351
pubmed: 27627784
Neurosci Lett. 1994 Jun 6;174(1):67-72
pubmed: 7970158
J Neurosci Methods. 2013 May 15;215(2):241-4
pubmed: 23537935
MethodsX. 2017 Dec 13;5:1-7
pubmed: 29276694
Adv Anat Embryol Cell Biol. 2015;215:1-162
pubmed: 25920101
J Neurosci Res. 2010 Aug 1;88(10):2083-90
pubmed: 20533377
Acta Neuropathol. 2021 Sep;142(3):423-448
pubmed: 34115198
Stain Technol. 1988 Jul;63(4):197-200
pubmed: 2464205
Brain. 2017 Dec 1;140(12):3204-3214
pubmed: 29177427
Acta Neuropathol. 2018 Feb;135(2):213-226
pubmed: 29273900
Nature. 2013 May 16;497(7449):332-7
pubmed: 23575631
Nat Protoc. 2014 Jul;9(7):1682-97
pubmed: 24945384
Front Neuroanat. 2015 Mar 05;9:23
pubmed: 25798091
Neuropathol Appl Neurobiol. 2016 Oct;42(6):573-87
pubmed: 26526972
Sci Rep. 2016 Feb 18;6:20833
pubmed: 26888634
Neurobiol Aging. 1990 Jan-Feb;11(1):29-37
pubmed: 2325814
Neurosci Lett. 1989 Aug 28;103(2):234-9
pubmed: 2505201
Front Cell Neurosci. 2019 Jun 12;13:256
pubmed: 31244613
Brain Res. 1979 Mar 16;163(2):195-205
pubmed: 427544
Mol Psychiatry. 2013 Apr;18(4):425-34
pubmed: 22925831
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Epilepsia. 2012 Jun;53 Suppl 1:45-52
pubmed: 22612808
Proc Natl Acad Sci U S A. 1995 Sep 12;92(19):8710-4
pubmed: 7568002
J Alzheimers Dis. 2011;24(3):547-57
pubmed: 21297265
Brain. 2012 Jul;135(Pt 7):2155-68
pubmed: 22637583
Front Neuroanat. 2009 Jun 09;3:7
pubmed: 19543540
Alzheimers Dement. 2016 Jun;12(6):633-44
pubmed: 26776762
Opt Express. 2014 Mar 24;22(6):7028-39
pubmed: 24664051
Nat Neurosci. 2018 May;21(5):671-682
pubmed: 29686261
Sci Rep. 2019 Mar 26;9(1):5181
pubmed: 30914681
Neurobiol Aging. 2013 Jan;34(1):286-97
pubmed: 22503003
Sci Rep. 2016 May 16;6:26013
pubmed: 27181107
Brain Struct Funct. 2015 Nov;220(6):3143-65
pubmed: 25031178
Acta Neuropathol. 2006 Oct;112(4):389-404
pubmed: 16906426
J Alzheimers Dis. 2008 Sep;15(1):139-51
pubmed: 18780974
Genome Biol. 2007;8(2):206
pubmed: 17316461
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
Histochem Cell Biol. 2001 Aug;116(2):119-30
pubmed: 11685540
Ann Neurol. 1990 May;27(5):457-64
pubmed: 2360787
Neuron. 2010 Dec 9;68(5):843-56
pubmed: 21144999
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
pubmed: 22002422
Methods Mol Biol. 2011;717:101-10
pubmed: 21370027
Histochem Cell Biol. 1996 Apr;105(4):261-7
pubmed: 9072183
eNeuro. 2019 Jul 10;6(4):
pubmed: 31217195
Nat Protoc. 2013;8(7):1366-80
pubmed: 23787894
J Struct Biol. 2016 Sep;195(3):345-352
pubmed: 27402534
Front Neurosci. 2016 Apr 25;10:179
pubmed: 27199642
Cell Rep. 2016 Jul 26;16(4):1138-1152
pubmed: 27425620
J Chem Neuroanat. 1992 Sep-Oct;5(5):383-90
pubmed: 1329844
Neurobiol Aging. 2006 Oct;27(10):1372-84
pubmed: 16289476
J Neurosci. 2013 Aug 7;33(32):13204-24
pubmed: 23926273
Opt Express. 2014 Jun 30;22(13):15982-91
pubmed: 24977854
Acta Neuropathol. 2014 Sep;128(3):457-9
pubmed: 25069432
Nat Commun. 2018 Mar 14;9(1):1066
pubmed: 29540691
Cell. 2014 Aug 14;158(4):945-958
pubmed: 25088144
Acta Neuropathol. 2009 Jul;118(1):167-79
pubmed: 19390859
Sci Rep. 2018 Jan 17;8(1):938
pubmed: 29343737
Mol Neurobiol. 2019 Oct;56(10):6833-6855
pubmed: 30929164
Neurology. 2002 Jun 25;58(12):1791-800
pubmed: 12084879
Front Cell Neurosci. 2016 Jan 12;9:496
pubmed: 26834559
Cold Spring Harb Perspect Biol. 2016 Nov 1;8(11):
pubmed: 27580631
Dementia. 1996 May-Jun;7(3):128-34
pubmed: 8740626